Lord Abbett Health Care I (LHCIX)
| Fund Assets | 8.67M |
| Expense Ratio | 0.78% |
| Min. Investment | $1,000,000 |
| Turnover | 91.00% |
| Dividend (ttm) | 0.08 |
| Dividend Yield | 0.34% |
| Dividend Growth | -24.95% |
| Payout Frequency | n/a |
| Ex-Dividend Date | Dec 2, 2025 |
| Previous Close | 24.32 |
| YTD Return | 7.74% |
| 1-Year Return | 34.36% |
| 5-Year Return | 27.25% |
| 52-Week Low | 18.22 |
| 52-Week High | 24.59 |
| Beta (5Y) | n/a |
| Holdings | 60 |
| Inception Date | Jul 31, 2019 |
About LHCIX
Lord Abbett Health Care Fund Class I is a mutual fund that seeks to achieve long-term capital growth by investing primarily in equities of companies operating within the health care sector. The fund’s portfolio features a diverse selection of businesses involved in pharmaceuticals, biotechnology, medical devices, health care services, and related sub-sectors. By concentrating on the health care industry, the fund aims to capitalize on trends such as medical innovation, demographic changes, and advancements in treatment and technology that drive growth within the sector. The fund typically holds around 60 different securities, providing broad exposure across various health care industries. Class I shares are most suitable for institutional investors, requiring a high minimum initial investment, but offer a lower net expense ratio compared to other share classes. The fund distributes dividends monthly and accrues them daily. Lord Abbett Health Care Fund Class I plays a specialized role in the market by offering investors targeted access to health care companies, making it a potential component for portfolios seeking sector-specific growth and diversification opportunities within the broader equity landscape.
Performance
LHCIX had a total return of 34.36% in the past year, including dividends. Since the fund's inception, the average annual return has been 10.54%.
Top 10 Holdings
38.34% of assets| Name | Symbol | Weight |
|---|---|---|
| Eli Lilly and Company | LLY | 9.06% |
| AstraZeneca PLC | AZN | 4.82% |
| Gilead Sciences, Inc. | GILD | 4.33% |
| Johnson & Johnson | JNJ | 3.25% |
| Nektar Therapeutics | NKTR | 3.23% |
| Natera, Inc. | NTRA | 2.97% |
| Tarsus Pharmaceuticals, Inc. | TARS | 2.88% |
| Guardant Health, Inc. | GH | 2.68% |
| argenx SE | ARGX | 2.61% |
| Novartis AG | NOVN | 2.52% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 2, 2025 | $0.0824 | Dec 2, 2025 |
| Nov 26, 2024 | $0.1098 | Nov 26, 2024 |
| Nov 22, 2022 | $0.0239 | Nov 22, 2022 |
| Nov 23, 2021 | $1.4724 | Nov 23, 2021 |
| Nov 24, 2020 | $2.3119 | Nov 24, 2020 |
| Nov 21, 2019 | $0.0073 | Nov 21, 2019 |